Sharlife is a Registered Shariah Advisory Firm with Securities Commission Malaysia - The only regulated provider of crypto & stocks Shariah status
Sharlife is a Registered Shariah Advisory Firm with Securities Commission Malaysia - The only regulated provider of crypto & stocks Shariah status
LAC Med Berhad, through its subsidiaries, specialises in the supply and integration of medical devices in Malaysia and Indonesia. The Group is an authorised distributor for third-party brands of medical devices, including medical equipment primarily used for diagnostic purposes, and associated products like medical consumables. It also provides software and system integration services. A key part of its business involves the provision of ICT products and services tailored for healthcare facilities. The company was incorporated in Malaysia in November 2024 and has since expanded its operations regionally with the establishment of PT Fairmed in Indonesia.
| Allocation | Shares | % |
|---|---|---|
| Malaysian Public | ||
| Bumiputera shareholders approved by MITI | ||
| Eligible Directors and employees | ||
| Private placement to selected investors and others |
| 31/12/2022 | 31/12/2023 | 31/12/2024 | % Growth | |
|---|---|---|---|---|
| Revenue | ||||
| Other Income | ||||
| Interest Income | ||||
| Profit After Tax | ||||
| PAT Margin % |
| 31/12/2022 | 31/12/2023 | 31/12/2024 | % Growth | |
|---|---|---|---|---|
| Non-current Assets | ||||
| Current Assets | ||||
| Non Current Liabilities | ||||
| Current Liabilities | ||||
| Deferred Liabilities | ||||
| Total Assets | ||||
| Total Liabilities |
| 31/12/2022 | 31/12/2023 | 31/12/2024 | % Growth | |
|---|---|---|---|---|
| Share Capital | ||||
| Retained Earnings | ||||
| Reserves | ||||
| Working Capital | ||||
| Shareholder Fund |
| 31/12/2022 | Score | 31/12/2023 | Score | 31/12/2024 | Score | % Growth | |
|---|---|---|---|---|---|---|---|
| Current Ratio (Liquidity) | |||||||
| Debt Ratio (Leverage) | |||||||
| Gearing Ratio (Leverage) | |||||||
| Return on Capital Employed | |||||||
| Total Assets Turnover |
| 31/12/2022 | 31/12/2023 | 31/12/2024 | Overall weighted score |
|---|---|---|---|
| Company P/E ratio | |
|---|---|
| Peers | P/E |
| Checklist | Remarks |
|---|---|
| IPO price & market cap | |
| Earnings base & EPS | |
| Implied P/E multiple | |
| Pro forma NA & P/B | |
| ROE and profitability | |
| Growth profile | |
| Order book & visibility | |
| Capital structure & gearing | |
| Use of proceeds & incremental ROIC | |
| Dividend policy & cash yield | |
| Customer mix & concentration | |
| Revenue |
